Colorectal cancer in inflammatory bowel disease: mechanisms and management
SC Shah, SH Itzkowitz - Gastroenterology, 2022 - Elsevier
Patients with inflammatory bowel disease (IBD) are at increased risk of developing
colorectal cancer (CRC), despite decreases in CRC incidence in recent years. Chronic …
colorectal cancer (CRC), despite decreases in CRC incidence in recent years. Chronic …
[HTML][HTML] Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
H Nakase, M Uchino, S Shinzaki, M Matsuura… - Journal of …, 2021 - Springer
Inflammatory bowel disease (IBD) is a general term for chronic or remitting/relapsing
inflammatory diseases of the intestinal tract and generally refers to ulcerative colitis (UC) …
inflammatory diseases of the intestinal tract and generally refers to ulcerative colitis (UC) …
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind …
S Danese, S Vermeire, W Zhou, AL Pangan… - The lancet, 2022 - thelancet.com
Background There is a great unmet need for advanced therapies that provide rapid, robust,
and sustained disease control for patients with ulcerative colitis. We assessed the efficacy …
and sustained disease control for patients with ulcerative colitis. We assessed the efficacy …
[HTML][HTML] Ozanimod as induction and maintenance therapy for ulcerative colitis
WJ Sandborn, BG Feagan, G D'Haens… - … England Journal of …, 2021 - Mass Medical Soc
Background Ozanimod, a selective sphingosine-1-phosphate receptor modulator, is under
investigation for the treatment of inflammatory bowel disease. Methods We conducted a …
investigation for the treatment of inflammatory bowel disease. Methods We conducted a …
[HTML][HTML] Mirikizumab as induction and maintenance therapy for ulcerative colitis
G D'Haens, M Dubinsky, T Kobayashi… - … England Journal of …, 2023 - Mass Medical Soc
Background Mirikizumab, a p19-directed antibody against interleukin-23, showed efficacy in
the treatment of ulcerative colitis in a phase 2 trial. Methods We conducted two phase 3 …
the treatment of ulcerative colitis in a phase 2 trial. Methods We conducted two phase 3 …
Current and future status of JAK inhibitors
DP McLornan, JE Pope, J Gotlib, CN Harrison - The lancet, 2021 - thelancet.com
An enhanced understanding of the importance of Janus kinase (JAK) and signal transducer
and activator of transcription (STAT) signalling in multiple disease states has led to an …
and activator of transcription (STAT) signalling in multiple disease states has led to an …
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH,
autoimmune hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; …
autoimmune hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; …
Effect of IBD medications on COVID-19 outcomes: results from an international registry
Objective We sought to evaluate COVID-19 clinical course in patients with IBD treated with
different medication classes and combinations. Design Surveillance Epidemiology of …
different medication classes and combinations. Design Surveillance Epidemiology of …
AGA clinical practice update on endoscopic surveillance and management of colorectal dysplasia in inflammatory bowel diseases: expert review
SK Murthy, JD Feuerstein, GC Nguyen, FS Velayos - Gastroenterology, 2021 - Elsevier
Improvements in disease management, as well as endoscopic technology and quality, have
dramatically changed the way in which we conceptualize and manage inflammatory bowel …
dramatically changed the way in which we conceptualize and manage inflammatory bowel …
The immunomodulatory functions of butyrate
MT Siddiqui, GAM Cresci - Journal of inflammation research, 2021 - Taylor & Francis
The gastrointestinal (GI) system contains many different types of immune cells, making it a
key immune organ system in the human body. In the last decade, our knowledge has …
key immune organ system in the human body. In the last decade, our knowledge has …